Form 8-K - Current report:
SEC Accession No. 0001193125-25-274216
Filing Date
2025-11-10
Accepted
2025-11-10 16:07:52
Documents
11
Period of Report
2025-11-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sprb-20251110.htm   iXBRL 8-K 52222
2 EX-99.1 sprb-ex99_1.htm EX-99.1 197853
  Complete submission text file 0001193125-25-274216.txt   379355

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT sprb-20251110.xsd EX-101.SCH 31969
13 EXTRACTED XBRL INSTANCE DOCUMENT sprb-20251110_htm.xml XML 4901
Mailing Address 611 GATEWAY BOULEVARD, SUITE 740 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BOULEVARD, SUITE 740 SOUTH SAN FRANCISCO CA 94080 (415) 655-4168
SPRUCE BIOSCIENCES, INC. (Filer) CIK: 0001683553 (see all company filings)

EIN.: 812154263 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39594 | Film No.: 251466215
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)